Cargando…

P1520: AN ACTIVIN RECEPTOR IIB LIGAND TRAP, IN COMBINATION WITH TMPRSS6 INDUCED IRON-RESTRICTION, IS A SUPERIOR TREATMENT FOR CORRECTING Β-THALASSEMIA IN MICE

Detalles Bibliográficos
Autores principales:	Guerra, A., Demsko, P., Sinha, S., McVeigh, P., Castruccio Castracani, C., Breda, L., Casu, C., Guo, S., Rivella, S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430760/ http://dx.doi.org/10.1097/01.HS9.0000848936.44628.f2

Ejemplares similares

S101: COMBINATION OF A LUSPATERCEPT-LIKE DRUG (RAP-GRL) AND TMPRSS6-ASO IS SUPERIOR TO EITHER DRUG ALONE FOR CORRECTING β-THALASSEMIA
por: Guerra, A., et al.
Publicado: (2022)

Gene Therapy in Thalassemia and Hemoglobinopathies
por: Breda, Laura, et al.
Publicado: (2009)

Activin Receptor-Ligand Trap for the Treatment of β-thalassemia: A Serendipitous Discovery
por: Brancaleoni, Valentina, et al.
Publicado: (2020)

Tmprss6-ASO as a tool for the treatment of Polycythemia Vera mice
por: Casu, Carla, et al.
Publicado: (2021)

S102: OBLIGATE N-TERMINAL BUT NOT C-TERMINAL MONOFERRIC TRANSFERRIN AMELIORATES ANEMIA IN β-THALASSEMIC MICE
por: Guerra, A., et al.
Publicado: (2022)

Recent trends in the gene therapy of β-thalassemia
por: Finotti, Alessia, et al.
Publicado: (2015)

The effects of a soluble activin type IIB receptor on obesity and insulin sensitivity
por: Akpan, Imo, et al.
Publicado: (2009)

Therapeutic Hemoglobin Levels after Gene Transfer in β-Thalassemia Mice and in Hematopoietic Cells of β-Thalassemia and Sickle Cells Disease Patients
por: Breda, Laura, et al.
Publicado: (2012)

Blockade of Activin Receptor IIB Protects Arthritis Pathogenesis by Non‐Amplification of Activin A‐ACVR2B‐NOX4 Axis Pathway
por: Jeon, Jimin, et al.
Publicado: (2023)

Macrophages support pathological erythropoiesis in Polycythemia Vera and Beta-Thalassemia
por: Ramos, Pedro, et al.
Publicado: (2013)

Molecular characteristic of activin receptor IIB and its functions in growth and nutrient regulation in Eriocheir sinensis
por: Wang, Jingan, et al.
Publicado: (2020)

Treatment with Soluble Activin Receptor Type IIB Alters Metabolic Response in Chemotherapy-Induced Cachexia
por: O’Connell, Thomas M., et al.
Publicado: (2019)

S104: A SEVERE MOUSE MODEL OF ALPHA-THALASSEMIA SHOWS ABNORMAL IRON METABOLISM, ERYTHROPOIESIS AND COAGULATION, AND CAN BE RESCUED BY A NOVEL GENE THERAPY APPROACH
por: Chappell, M, et al.
Publicado: (2022)

A Soluble Activin Receptor Type IIB Does Not Improve Blood Glucose in Streptozotocin-Treated Mice
por: Wang, Qian, et al.
Publicado: (2015)

Minihepcidins improve ineffective erythropoiesis and splenomegaly in a new mouse model of adult β-thalassemia major
por: Casu, Carla, et al.
Publicado: (2020)

β-Thalassemia: HiJAKing Ineffective Erythropoiesis and Iron Overload
por: Melchiori, Luca, et al.
Publicado: (2010)

TMPRSS6 as a Therapeutic Target for Disorders of Erythropoiesis and Iron Homeostasis
por: Ganz, Tomas, et al.
Publicado: (2023)

Soluble activin type IIB receptor improves fracture healing in a closed tibial fracture mouse model
por: Puolakkainen, Tero, et al.
Publicado: (2017)

Treatment with Soluble Activin Type IIB Receptor Ameliorates Ovariectomy-Induced Bone Loss and Fat Gain in Mice
por: Puolakkainen, Tero, et al.
Publicado: (2022)

Lambda(1520) Production in Hadronic Z Decays
por: Seeman, F, et al.
Publicado: (1998)

$\Lambda$(1520) production in hadronic Z decays
por: Seemann, F, et al.
Publicado: (1999)

Relación de 1520, de Hernán Cortés
por: Rodríguez, María Teresa
Publicado: (2023)

$\Lambda$ (1520) production at SPS and RHIC energies
por: Markert, C
Publicado: (2002)

Y0* (1520) production and decay in the reaction K−n → Y0*(1520) $\pi^{-}$ at 3 GeV/c
por: Scheuer, J C, et al.
Publicado: (1968)

Inclusive $\Sigma^{-}$ and $\Lambda(1520)$ production in hadronic Z decays
por: Abreu, P., et al.
Publicado: (2000)

P1521: A SEVERE MOUSE MODEL OF ALPHA-THALASSEMIA SHOWS ABNORMAL IRON METABOLISM, ERYTHROPOIESIS AND COAGULATION, AND CAN BE RESCUED BY A NOVEL GENE THERAPY APPROACH
por: Rivella, S., et al.
Publicado: (2022)

Activin Receptor Type IIB Inhibition Improves Muscle Phenotype and Function in a Mouse Model of Spinal Muscular Atrophy
por: Liu, Min, et al.
Publicado: (2016)

A validated cellular biobank for β-thalassemia
por: Cosenza, Lucia Carmela, et al.
Publicado: (2016)

Elevated CDKN1A (P21) mediates β-thalassemia erythroid apoptosis, but its loss does not improve β-thalassemic erythropoiesis
por: Liang, Raymond, et al.
Publicado: (2023)

A study of the decay $Lambda$(1520)$\rightarrow\Sigma(1385)pi$
por: Burkhardt, E E, et al.
Publicado: (1971)

A silent H-bond can be mutationally activated for high-affinity interaction of BMP-2 and activin type IIB receptor
por: Weber, Dionys, et al.
Publicado: (2007)

Treatment with soluble activin type IIB-receptor improves bone mass and strength in a mouse model of Duchenne muscular dystrophy
por: Puolakkainen, Tero, et al.
Publicado: (2017)

La España de los Reyes Católicos, 1474-1520 /
por: Edwards, John, 1949-
Publicado: (2001)

Abstract: 15.20 Revisited Fascia Lata In Facial Palsy
por: Puddu, Antonella, et al.
Publicado: (2017)

Inclusive Lambda (1520) production in 100 GeV p Be interactions
por: Daum, C, et al.
Publicado: (1982)

Observation of two JPC = O$^{++}$ isoscalar resonances at 1365 and 1520 MeV
por: Anisovich, V V, et al.
Publicado: (1994)

A combined approach for β-thalassemia based on gene therapy-mediated adult hemoglobin (HbA) production and fetal hemoglobin (HbF) induction
por: Zuccato, Cristina, et al.
Publicado: (2012)

EHA Research Roadmap on Hemoglobinopathies and Thalassemia: An Update
por: Iolascon, Achille, et al.
Publicado: (2019)

Blockade of activin type II receptors with a dual anti-ActRIIA/IIB antibody is critical to promote maximal skeletal muscle hypertrophy
por: Morvan, Frederic, et al.
Publicado: (2017)

Production of f'(1520) in 8.25 GeV/c K$^{-}$p interactions
por: Al-Harran, S, et al.
Publicado: (1981)

Cannot write session to /tmp/vufind_sessions/sess_j5uslibetfmv4o5ggpotifcunl